Complicated Regulatory Odyssey Steers FDA Toward Rule On CBD In Supplements

Before Congress de-scheduled hemp at end of 2018 and forced agency's hand on considering lawful use of ingredients derived from the plant in supplements and food, the floodgate for sales of the products was opened in 2013 by a DoJ policy change to de-emphasize enforcement of most federal marijuana laws.

a series of CBD oil bottle isolated on white

The deck already was stacked against the US Food and Drug Administration when Congress de-scheduled hemp at the end of 2018 and forced the agency's hand on considering making lawful the use of ingredients derived from the plant in dietary supplements and food.

More from Regulation

More from Policy & Regulation